Analyst Ratings for Maxim Integrated Products (MXIM)
MXIM Rating Summary
MXIM Price Target Summary
- Highest: $40.00 (Jefferies)
- Lowest: $16.00 (Citadel Securities)
- Average: $31.79
Overall Rating:
BUY
Rating Trend:
Avg. $ Target:
$31.79 (+5.7%)
Avg. $ Target:
$31.79 (+5.7%)
| Date | Firm | Type | Rating (Past) |
PT (Past) |
Start $ | End $ | % Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 1/15/2013 | Oppenheimer | Upgrade | Outperform (Perform) |
38.00 (N/A) |
29.15 | 30.08 | 3.19% | Details |
| 1/14/2013 | Credit Suisse | Downgrade | Neutral (Outperform) |
N/A (N/A) |
29.61 | 30.08 | 1.59% | Details |
| 1/11/2013 | JPMorgan | Upgrade | Overweight (Neutral) |
35.00 (26.00) |
29.64 | 30.08 | 1.48% | Details |
| 11/29/2012 | SunTrust Robinson Humphrey | New Coverage | Buy (N/A) |
33.00 (N/A) |
28.85 | 30.08 | 4.26% | Details |
| 9/27/2012 | Jefferies » Updated 4/26/2013 |
Upgrade | Buy (Hold) |
40.00 (38.00) |
26.09 | 30.08 | 15.29% | Details |
| 5/31/2012 | Morgan Stanley | New Coverage | Overweight (N/A) |
N/A (N/A) |
25.41 | 30.08 | 18.38% | Details |
| 4/27/2012 | Caris & Co. | Upgrade | Above Average (N/A) |
33.00 (N/A) |
28.91 | 30.08 | 4.05% | Details |
| 2/22/2012 | Capstone Investments | New Coverage | Buy (N/A) |
36.00 (N/A) |
27.69 | 30.08 | 8.63% | Details |
| 2/16/2012 | RBC Capital » Updated 1/25/2013 |
New Coverage | Outperform (N/A) |
33.00 (32.00) |
27.66 | 30.08 | 8.75% | Details |
| 11/18/2011 | Cantor Fitzgerald | New Coverage | Buy (N/A) |
35.00 (N/A) |
25.76 | 30.08 | 16.77% | Details |
| 9/19/2011 | UBS » Updated 9/6/2012 |
Upgrade | Buy (N/A) |
32.00 (N/A) |
25.32 | 30.08 | 18.8% | Details |
| 9/12/2011 | Susquehanna | Upgrade | Positive (N/A) |
28.00 (N/A) |
23.11 | 30.08 | 30.16% | Details |
| 8/11/2011 | Longbow Research | Downgrade | Neutral (N/A) |
28.00 (N/A) |
21.73 | 30.08 | 38.43% | Details |
| 5/23/2011 | Goldman Sachs » Updated 9/6/2012 |
Upgrade | Neutral (N/A) |
27.00 (25.00) |
27.29 | 30.08 | 10.22% | Details |
| 4/5/2011 | Cowen | Downgrade | Neutral (N/A) |
N/A (N/A) |
25.34 | 30.08 | 18.71% | Details |
